Literature DB >> 11231274

A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.

S Freeman1, H C Birrell, K D'Alessio, C Erickson-Miller, K Kikly, P Camilleri.   

Abstract

The siglecs (sialic acid-binding immunoglobulin-like lectins) mediate sialic acid-dependent cellular interactions and may in some cases signal through SH2-binding domains. In addition to the previously characterized siglecs, sialoadhesin, CD22, CD33 and myelin-associated glycoprotein, several new ones, siglec-5, siglec-7 and siglec-8, have recently been cloned. Although these novel receptors have generated considerable interest as therapeutic targets because of their expression pattern on immune cells, very little is known about how their lectin activity is regulated. Previous studies with sialoadhesin, CD22 and CD33 have shown that siglec glycosylation has significant effects on binding. To determine any differences in the glycan composition of siglec-5, siglec-7 and siglec-8 that may modify their function, we released and characterized the N-linked oligosaccharide distribution in these three glycoproteins. The glycan pools from siglec-5 and siglec-7 contained a larger proportion of sialylated and core-fucosylated biantennary, triantennary and tetra-antennary oligosaccharides, whereas the carbohydrate mixture released from siglec-8 is noticeably less sialylated and is more abundant in 'high-mannose'-type glycans. In addition, we show that, in contrast with CD22 and CD33, mutating the conserved potentially N-linked glycosylation site in the first domain has no effect on binding mediated by siglec-5 or siglec-7.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231274     DOI: 10.1046/j.1432-1327.2001.01985.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

Review 1.  Molecular diversity and evolution of the Siglec family of cell-surface lectins.

Authors:  Takashi Angata
Journal:  Mol Divers       Date:  2006-11       Impact factor: 3.364

2.  A new approach for extracting information from protein dynamics.

Authors:  Jenny Liu; Luís A N Amaral; Sinan Keten
Journal:  ArXiv       Date:  2022-03-16

3.  Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

Authors:  Ju-Yi Li; Xiao-Yan Yang; Xiu-Fang Wang; Xiong Jia; Zhong-Jing Wang; Ai-Ping Deng; Xiang-Li Bai; Lin Zhu; Bing-Hui Li; Zi-Bo Feng; Ye Li; Ling Wang; Si Jin
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.